Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1996-2-28
|
pubmed:abstractText |
This study determined the effect of the polypeptide growth factors transforming growth factor-beta (TGF-beta), insulin-like growth factor-I (IGF-I), and growth hormone (GH) alone and in combination with dietary L-Arginine HCL (ARG) on skin flap survival in rats. Caudally based dorsal skin flaps were created in 110 Sprague-Dawley rats. The rats were randomly assigned into three treatment groups, based on drinking water supplementation. Group 1 (n = 50) received ARG in their drinking water, group 2 (n = 50) received tap water alone, and group 3 (n = 10) received N-omega-nitro-L-arginine (L-NA) and hydralazine. Groups 1 and 2 were divided into subgroups of 10 rats each based on treatment with either: TGF-beta, IGF-I, GH, or IGF-I + GH. All subgroups that received GH had significantly greater (P < .0001) median body weight gains when compared with subgroups not receiving GH. L-arginine HCL when added to IGF-I negated the positive effects of IGF-I on both flap survival and weight gain. Although the rats in all subgroups from groups 1 and 2 had an increase in mean percent skin flap survival when compared with the water alone subgroup, only rats receiving IGF-I, or the combination of ARG with either TGF-beta or GH, had statistically significant enhanced skin flap survival. Rats in group 3 did not show an increase in skin flap survival when compared with the control subgroup.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arginine,
http://linkedlifedata.com/resource/pubmed/chemical/Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Growth Substances,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0161-3499
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
484-91
|
pubmed:dateRevised |
2011-4-25
|
pubmed:meshHeading |
pubmed-meshheading:8560743-Animals,
pubmed-meshheading:8560743-Arginine,
pubmed-meshheading:8560743-Drug Therapy, Combination,
pubmed-meshheading:8560743-Graft Survival,
pubmed-meshheading:8560743-Growth Hormone,
pubmed-meshheading:8560743-Growth Substances,
pubmed-meshheading:8560743-Insulin-Like Growth Factor I,
pubmed-meshheading:8560743-Ischemia,
pubmed-meshheading:8560743-Male,
pubmed-meshheading:8560743-Postoperative Complications,
pubmed-meshheading:8560743-Rats,
pubmed-meshheading:8560743-Rats, Sprague-Dawley,
pubmed-meshheading:8560743-Surgical Flaps,
pubmed-meshheading:8560743-Transforming Growth Factor beta
|
pubmed:articleTitle |
Effects of growth factors and L-arginine on ischemic skin flaps in rats.
|
pubmed:affiliation |
Department of Pathology, University of California, School of Veterinary Medicine, Davis 95616-8745, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|